Choi, S. W., Stiff, P., Cooke, K., Ferrara, J. L., Braun, T., Kitko, C., . . . Levine, J. E. (2012). TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcomes.
शिकागो स्टाइल उद्धरणChoi, Sung W., et al. TNF-inhibition With Etanercept for Graft Versus Host Disease Prevention in High Risk HCT: Lower TNFR1 Levels Correlate With Better Outcomes. 2012.
एमएलए उद्धरणChoi, Sung W., et al. TNF-inhibition With Etanercept for Graft Versus Host Disease Prevention in High Risk HCT: Lower TNFR1 Levels Correlate With Better Outcomes. 2012.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.